ScottEggenerMD

Surgical Oncology

Associate Professor of Surgery The University of Chicago Medicine Co-Director, Prostate Cancer Program Director of Translational and Outcomes Research, Section of Urology

Join to view full profile

Dr. Eggener is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eggener's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-702-1001

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Urology, 2001 - 2005
McGaw Medical Center of Northwestern UniversityResidency, Surgery, 1999 - 2001
Stanford University School of MedicineClass of 1999

Certifications & Licensure

IL State Medical License 2002 - 2026
IN State Medical License 2016 - 2025
ND State Medical License 2008 - 2010
NY State Medical License 2005 - 2008
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA) Start of enrollment: 2009 Jan 01
Terminated
Phase 3
Laser Based Focal Ablation of Low Grade Prostate Cancer Start of enrollment: 2010 Jan 01
Completed
Not Applicable
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2013 Jan 28
Completed
Not Applicable
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer Start of enrollment: 2016 Sep 21
Active, not recruiting
Not Applicable
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer Start of enrollment: 2016 Nov 01
Completed
Phase 2, Phase 3
Stockholm3 Validation Study in a Multi-Ethnic Cohort Start of enrollment: 2019 Dec 15
Completed
Join now to see all

Publications & Presentations

PubMed

Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky
BJU International. 2024-12-11
Genomic Classifiers To Guide Postprostatectomy Radiation Therapy: An Opening Movement in G-MINOR.
Scott Eggener, Stanley L Liauw
European Urology. 2024-11-29
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study.
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, Ashish Khanna, Amitabh Singh
European Urology Focus. 2024-11-16

Journal Articles

Evaluation of Tumour Coverage After MR‐Guided Prostate Focal Laser Ablation Therapy
Aytekin Oto, Scott Eggener, Medical Physics
“Real-World” Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate Cancer
Edward M Schaeffer, Scott E Eggener, European Urology
Comparison of Perioperative and Early Oncologic Outcomes Between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort
Joseph J Pariser, Sanjay G Patel, Scott E Eggener, Shane M Pearce, The Journal of Urology

Press Mentions

Experts Call for Early Stage Prostate Cancer to Be Reclassified as Pre-CancerMay 13th, 2023
UChicago Medicine Clinical Trial Evaluates New Prostate Cancer Screening Technique for High-Risk PatientsMay 4th, 2023
If It Resembles Cancer but Doesn't Act like Cancer, Is It Cancer?February 16th, 2023
Join now to see all